-
The research group of Prof. Dr. Michael Mastalerz at the Institute of Organic Chemistry, Heidelberg University is seeking the following temporary position from October 15th 2025 or later: PhD
-
Stellenanzeige teilen wanted for the next possible date at the Department of Pediatric Oncology, Hematology and Immunology . Osteosarcoma (OS) is an aggressive bone cancer mainly affecting children and young
-
candidates with a background in cell cycle regulation/mitosis and cell biology. The duration of mitosis is tightly regulated by multiple factors, including the spindle assembly checkpoint (SAC
-
focusses on the development and translation of a novel peptide therapy against cardiac diseases. It is based on extensive preliminary work by our working group, which has demonstrated therapeutic effects
-
against cardiac diseases. It is based on extensive preliminary work by our working group, which has demonstrated therapeutic effects of the synthetic peptide in chronic and acute heart failure animal models
-
the ability to work both independently and collaboratively. Experience in animal experimentation is a plus. Enthusiasm for onco-immunology and microbiome research and the drive to contribute to scientific
-
Stellenanzeige teilen wanted for the next possible date at the Clinic for Child and Asolescent Psychiatry and Psychotherapy. The Department of Child and Adolescent Psychiatry, led by Prof. L. Poustka, is committed
-
glioblastoma with a distinct focus on IDH mutations, aiming at determining factors influencing the IDH-dependent gliomagenesis and malignant progression. The lab is integrated into the department of Neurology
-
Heidelberg University is a comprehensive university with a strong focus on research and international standards. With around 31,300 students and 8,400 employees, including numerous top researchers
-
About the Position: The successful candidate will join the project group of PD Dr. Axel Mogk, renowned for his work on bacterial protein quality control systems. The hexameric AAA+ proteins ClpG and